Can copper and zinc imbalance affect immune function and red blood cell biology?

Copper and zinc maintain a delicate homeostatic balance regulated during intestinal absorption, where an excess of one directly impairs the physiological status of the other.

Mechanistic pathways of competition

• Metallothionein induction: High intestinal zinc levels—frequently driven by zinc supplement doses exceeding 50 mg/day—activate the metal-regulatory transcription factor 1 (MTF-1), significantly upregulating the metal-binding protein metallothionein (MT) within enterocytes.
• Copper sequestration: Because MT has a higher binding affinity for copper than for zinc, it preferentially traps copper inside the enterocytes. This prevents copper from utilizing the basolateral exporter ATP7A to enter portal circulation, causing it to be shed and excreted in feces.

Hematological and immunological impacts

• Immune dysfunction: The resulting systemic copper deficiency compromises hematopoietic progenitor differentiation and mature neutrophil survival, presenting as neutropenia and leukopenia. Circulating CD2⁺, CD4⁺, and CD20⁺ lymphocytes may also decrease.
• Disrupted red blood cell biology: Copper depletion impairs iron mobilization, manifesting as microcytic, normocytic, or macrocytic anemia. Bone marrow biopsies frequently reveal vacuolated erythroid precursors and ring sideroblasts, which can be misdiagnosed as myelodysplastic syndrome.

Bottom line

• High-dose zinc intake (>50 mg/day) drives a metallothionein-mediated copper deficiency that impairs white and red blood cell production; however, correcting the copper-zinc imbalance and halting excess zinc exposure fully reverses these cytopenias within 4 to 12 weeks.